| Literature DB >> 29920366 |
Makswell Almeida Silva1, Daiana Silva Lopes1, Samuel Cota Teixeira2, Sarah Natalie Cirilo Gimenes1, Fernanda Van Petten Vasconcelos Azevedo1, Lorena Polloni3, Bruna Cristina Borges4, Marcelo Santos da Silva5, Marcelo José Barbosa4, Robson José de Oliveira Júnior3, Maria Carolina Elias5, Claudio Vieira da Silva2, Kelly Aparecida Geraldo Yoneyama1, Veridiana de Melo Rodrigues6, Renata Santos Rodrigues7.
Abstract
Herein we evaluated the genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) from Bothrops pauloensis, on breast cancer cells. BnSP-6 was able to induce a higher cytotoxic and genotoxic activity in MDA-MB-231 cells, when compared to MCF10A (a non-tumorigenic breast cell line), suggesting that this protein presented a possible preference for cancer cells. BnSP-6 inhibited MDA-MB-231 proliferation at 24, 48 and 72 h. In addition, BnSP-6 induced significant increase in the percentage of TUNEL-positive cells, a marker of DNA damage. To obtain novel insight into the direct DNA damage interference in MDA-MB-231 survival and proliferation, we evaluated cell cycle progression. BnSP-6 produced a significant decrease in 2N (G1) and an increase in the G2/M phase and this capacity is likely related to the modulation of expression of progression cell cycle-associated genes (CCND1, CCNE1, CDC25A, CHEK2, E2F1, CDH-1 and NF-kB). Taken together, these results indicate that BnSP-6 induces DNA damage in breast cancer cells and is an attractive model for developing innovative therapeutic agents against breast cancer.Entities:
Keywords: BnSP-6; Bothrops pauloensis; Breast cancer; Cell cycle; Genotoxicity; PLA(2)
Mesh:
Substances:
Year: 2018 PMID: 29920366 DOI: 10.1016/j.ijbiomac.2018.06.082
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953